Even though diagnosis and management pathways have been substantially improved over
the last years, autoimmune rheumatic diseases (AIRDs) such as rheumatoid arthritis (RA),
systemic sclerosis (SSc), systemic lupus erythematosus (SLE), antiphospholipid syndrome
(APS), Sjögren's syndrome (SS) and systemic vasculitides (SVs) have been linked to
elevated rates of cardiovascular morbidity and mortality, primarily secondary to accelerated
atherosclerosis. This phenomenon can be partially attributed to the presence of established …